Multicenter evaluation of the new Alinity s anti-HCV II assay for routine hepatitis C virus blood screening

Wai‐Chiu Tsoi(Chinese University of Hong Kong), Sonu Bhatnagar(Abbott (Singapore)), Lisa Jarvis(Edinburgh Royal Infirmary), Ramunė Šepetienė(Abbott (Germany)), Ninette Robbins(Abbott Fund), Alan Р. Smith(University of California, Berkeley), Catriona Simpson(Scottish National Blood Transfusion Service)

Journal of Clinical Virology Plus

January 11, 2023

10.1016/j.jcvp.2023.100136

Cited by 2

Related Papers

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009

|Vox Sanguinis|2011|191

Frequent Reinfection And Reactivation Of Hepatitis C Virus Genotypes In Multitransfused Hemophiliacs

|The Journal of Infectious Diseases|1994|133

Detection of different categories of hepatitis B virus (HBV) infection in a multi‐regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV‐DNA testing

|Transfusion|2016|78

Donors with a rare pheno (geno) type

|Vox Sanguinis|2008|54

Enhanced detection of hepatitis <scp>B</scp> virus in <scp>H</scp>ong <scp>K</scp>ong blood donors after introduction of a more sensitive transcription‐mediated amplification assay

|Transfusion|2013|46